![Michel Baijot](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michel Baijot
Direttore/Membro del Consiglio presso
EXPRES2ION BIOTECH HOLDING AB
Profilo
Michel Baijot is currently Chairman at OncoRadiomics SA since 2018, Chairman at Curavac, Inc., Director at Antelope Dx BV, Director at Antelope Diagnostics since 2020, Director at Expres2ion Biotech Holding AB starting 2026, and President at White Fund SA since 2019.
Former roles include Chief Executive Officer, MD & Director at European Medical Solutions from 2018 to 2020, Executive Director-Europe Region at Serum Institute of India Pvt Ltd. from 2016 to 2017, Director at Ire EliT NV from 2015 to 2018, Vice President-Business Development at Fujirebio Europe NV from 2000 to 2005, Vice President-Business Development at GlaxoSmithKline Biologicals SA from 2005 to 2011, and Chief Business Officer & Head-Cipla Global Vaccine at Janssen, Inc. from 2011 to 2014.
Education includes a doctorate from Université Catholique de Louvain.
Posizioni attive di Michel Baijot
| Società | Posizione | Inizio |
|---|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Direttore/Membro del Consiglio | 01/04/2026 |
OncoRadiomics SA
 OncoRadiomics SA Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Presidente | 01/01/2018 |
White Fund SA
 White Fund SA Investment ManagersFinance Acts as Venture Capital Fund | Presidente | 01/01/2019 |
Antelope Diagnostics | Direttore/Membro del Consiglio | 01/09/2020 |
Antelope Dx BV
 Antelope Dx BV Packaged SoftwareTechnology Services Develops a point-of-need diagnostics platform that allows patients, consumers and healthcare professionals to have on-the-spot access to key health parameters | Direttore/Membro del Consiglio | - |
Curavac, Inc.
 Curavac, Inc. BiotechnologyHealth Technology Develops therapeutic vaccines against autoimmune diseases | Presidente | - |
White Fund
 White Fund Investment ManagersFinance Functions as an alternative investment manager | Presidente | - |
Precedenti posizioni note di Michel Baijot
| Società | Posizione | Fine |
|---|---|---|
IRE ELiT SRL
 IRE ELiT SRL Pharmaceuticals: MajorHealth Technology Manufactures radiopharmaceutical products | Direttore/Membro del Consiglio | 01/01/2018 |
Serum Institute of India Pvt Ltd.
 Serum Institute of India Pvt Ltd. BiotechnologyHealth Technology Manufactures vaccines and immunobiological products | Corporate Officer/Principal | 01/01/2017 |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░░░ ░░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Michel Baijot
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
34
Relazioni di 1° grado
14
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 14 |
|---|---|
Fujirebio Europe NV
 Fujirebio Europe NV Medical SpecialtiesHealth Technology Develops and markets diagnostic products to improve therapy management and patient health | Health Technology |
GlaxoSmithKline Biologicals SA
 GlaxoSmithKline Biologicals SA BiotechnologyHealth Technology Operates biopharma and pharmaceutical company | Health Technology |
Serum Institute of India Pvt Ltd.
Serum Institute of India Pvt Ltd. BiotechnologyHealth Technology Manufactures vaccines and immunobiological products | Health Technology |
European Medical Solutions
 European Medical Solutions BiotechnologyHealth Technology Develops tools for diagnosis and treatment of immune response-related diseases | Health Technology |
Université Catholique de Louvain
 Université Catholique de Louvain Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Janssen, Inc.
 Janssen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
Expres2ion Biotech Holding AB
 Expres2ion Biotech Holding AB BiotechnologyHealth Technology Engages in the development of a portfolio of vaccines for diseases such as COVID-19, influenza, and breast cancer | Health Technology |
Curavac, Inc.
Curavac, Inc. BiotechnologyHealth Technology Develops therapeutic vaccines against autoimmune diseases | Health Technology |
OncoRadiomics SA
OncoRadiomics SA Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
IRE ELiT SRL
IRE ELiT SRL Pharmaceuticals: MajorHealth Technology Manufactures radiopharmaceutical products | Health Technology |
Antelope Dx BV
Antelope Dx BV Packaged SoftwareTechnology Services Develops a point-of-need diagnostics platform that allows patients, consumers and healthcare professionals to have on-the-spot access to key health parameters | Technology Services |
White Fund SA
White Fund SA Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Antelope Diagnostics | |
White Fund
White Fund Investment ManagersFinance Functions as an alternative investment manager | Finance |
